{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T10:17:25Z","timestamp":1793528245402,"version":"4.5.0"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"7","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Human mesenchymal stem cells (MSC) strongly repress activated T-cell proliferation through the production of a complex set of soluble factors, including the tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase (IDO), which is induced by IFN-\u03b3. Conversely, MSCs support survival of follicular lymphoma (FL) B cells, in particular after exposure to tumor necrosis factor-\u03b1 (TNF) and lymphotoxin-\u03b11\u03b22 (LT). The role of MSCs on normal and malignant B-cell growth in steady-state and inflammatory conditions remains to be fully explored. We show here that resting MSCs sustain activated normal B-cell proliferation and survival, whereas IFN-\u03b3\u2013conditioned MSCs mediate IDO\u2013dependent B-cell growth arrest and apoptosis. IFN-\u03b3, TNF, and LT are significantly overexpressed by the microenvironment of invaded FL-lymph nodes, but their relative expression patterns are highly heterogeneous between samples. In vitro, IFN-\u03b3 abrogates the B-cell supportive phenotype induced by TNF and LT on MSCs. Moreover, IFN-\u03b3 overrules the growth promoting effect of MSCs on primary purified FL B cells. Altogether, these results underline the crucial role of the cytokine context in the local crosstalk between malignant cells and their microenvironment and provide new insights into our knowledge of the FL cell niche that emerges as a new promising target for innovative therapeutic strategies. [Cancer Res 2009;69(7):3228\u201337]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-3000","type":"journal-article","created":{"date-parts":[[2009,3,10]],"date-time":"2009-03-10T22:26:11Z","timestamp":1236723971000},"page":"3228-3237","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Functional Alteration of the Lymphoma Stromal Cell Niche by the Cytokine Context: Role of Indoleamine-2,3 Dioxygenase"],"prefix":"10.1158","volume":"69","author":[{"given":"He\u0301le\u0300ne","family":"Maby-El Hajjami","sequence":"first","affiliation":[{"name":"1Institut National de la Sante et de la Recherche Medicale U917, IFR140, Universite\u0301 Rennes 1, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Ame\u0301-Thomas","sequence":"additional","affiliation":[{"name":"1Institut National de la Sante et de la Recherche Medicale U917, IFR140, Universite\u0301 Rennes 1, France;"},{"name":"2Po\u0302le Cellules et Tissus,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ce\u0301line","family":"Pangault","sequence":"additional","affiliation":[{"name":"1Institut National de la Sante et de la Recherche Medicale U917, IFR140, Universite\u0301 Rennes 1, France;"},{"name":"2Po\u0302le Cellules et Tissus,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Tribut","sequence":"additional","affiliation":[{"name":"3Laboratoire de Pharmacologie, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"DeVos","sequence":"additional","affiliation":[{"name":"5Institut National de la Sante et de la Recherche Medicale U847, CHU Montpellier, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Jean","sequence":"additional","affiliation":[{"name":"2Po\u0302le Cellules et Tissus,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nade\u0300ge","family":"Bescher","sequence":"additional","affiliation":[{"name":"2Po\u0302le Cellules et Tissus,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ce\u0301line","family":"Monvoisin","sequence":"additional","affiliation":[{"name":"1Institut National de la Sante et de la Recherche Medicale U917, IFR140, Universite\u0301 Rennes 1, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe\u0308lle","family":"Dulong","sequence":"additional","affiliation":[{"name":"1Institut National de la Sante et de la Recherche Medicale U917, IFR140, Universite\u0301 Rennes 1, France;"},{"name":"6EFS Bretagne, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Lamy","sequence":"additional","affiliation":[{"name":"1Institut National de la Sante et de la Recherche Medicale U917, IFR140, Universite\u0301 Rennes 1, France;"},{"name":"4Service d'He\u0301matologie Clinique, CHU Rennes, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Fest","sequence":"additional","affiliation":[{"name":"1Institut National de la Sante et de la Recherche Medicale U917, IFR140, Universite\u0301 Rennes 1, France;"},{"name":"2Po\u0302le Cellules et Tissus,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Tarte","sequence":"additional","affiliation":[{"name":"1Institut National de la Sante et de la Recherche Medicale U917, IFR140, Universite\u0301 Rennes 1, France;"},{"name":"2Po\u0302le Cellules et Tissus,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2009,4,1]]},"reference":[{"key":"2022061701474872500_B1","doi-asserted-by":"crossref","unstructured":"Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science\u20081999; 284: 143\u20137.","DOI":"10.1126\/science.284.5411.143"},{"key":"2022061701474872500_B2","doi-asserted-by":"crossref","unstructured":"Horwitz EM, Le Blanc K, Dominici M, et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy\u20082005; 7: 393\u20135.","DOI":"10.1080\/14653240500319234"},{"key":"2022061701474872500_B3","doi-asserted-by":"crossref","unstructured":"Ramasamy R, Lam EW, Soeiro I, Tisato V, Bonnet D, Dazzi F. Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia\u20082007; 21: 304\u201310.","DOI":"10.1038\/sj.leu.2404489"},{"key":"2022061701474872500_B4","doi-asserted-by":"crossref","unstructured":"Djouad F, Plence P, Bony C, et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood\u20082003; 102: 3837\u201344.","DOI":"10.1182\/blood-2003-04-1193"},{"key":"2022061701474872500_B5","doi-asserted-by":"crossref","unstructured":"Spaeth E, Klopp A, Dembinski J, Andreeff M, Marini F. Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther\u20082008; 15: 730\u20138.","DOI":"10.1038\/gt.2008.39"},{"key":"2022061701474872500_B6","doi-asserted-by":"crossref","unstructured":"Karnoub AE, Dash AB, Vo AP, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature\u20082007; 449: 557\u201363.","DOI":"10.1038\/nature06188"},{"key":"2022061701474872500_B7","doi-asserted-by":"crossref","unstructured":"Mishra PJ, Humeniuk R, Medina DJ, et al. Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res\u20082008; 68: 4331\u20139.","DOI":"10.1158\/0008-5472.CAN-08-0943"},{"key":"2022061701474872500_B8","doi-asserted-by":"crossref","unstructured":"Uccelli A, Moretta L, Pistoia V. Immunoregulatory function of mesenchymal stem cells. Eur J Immunol\u20082006; 36: 2566\u201373.","DOI":"10.1002\/eji.200636416"},{"key":"2022061701474872500_B9","doi-asserted-by":"crossref","unstructured":"Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood\u20082007; 110: 3499\u2013506.","DOI":"10.1182\/blood-2007-02-069716"},{"key":"2022061701474872500_B10","doi-asserted-by":"crossref","unstructured":"Krampera M, Cosmi L, Angeli R, et al. Role for IFN-\u03b3 in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells\u20082006; 24: 386\u201398.","DOI":"10.1634\/stemcells.2005-0008"},{"key":"2022061701474872500_B11","doi-asserted-by":"crossref","unstructured":"Ryan JM, Barry F, Murphy JM, Mahon BP. Interferon-\u03b3 does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol\u20082007; 149: 353\u201363.","DOI":"10.1111\/j.1365-2249.2007.03422.x"},{"key":"2022061701474872500_B12","doi-asserted-by":"crossref","unstructured":"Polchert D, Sobinsky J, Douglas G, et al. IFN-\u03b3 activation of mesenchymal stem cells for treatment and prevention of graft versus host disease. Eur J Immunol\u20082008; 38: 1745\u201355.","DOI":"10.1002\/eji.200738129"},{"key":"2022061701474872500_B13","doi-asserted-by":"crossref","unstructured":"Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood\u20082004; 103: 4619\u201321.","DOI":"10.1182\/blood-2003-11-3909"},{"key":"2022061701474872500_B14","doi-asserted-by":"crossref","unstructured":"Munn DH, Mellor AL. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest\u20082007; 117: 1147\u201354.","DOI":"10.1172\/JCI31178"},{"key":"2022061701474872500_B15","doi-asserted-by":"crossref","unstructured":"Selmani Z, Naji A, Zidi I, et al. HLA-G5 secretion by Human mesenchymal stem cells is required to suppress T-LYMPHOCYTE and NK function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells\u20082008; 26: 212\u201322.","DOI":"10.1634\/stemcells.2007-0554"},{"key":"2022061701474872500_B16","doi-asserted-by":"crossref","unstructured":"Corcione A, Benvenuto F, Ferretti E, et al. Human mesenchymal stem cells modulate B-cell functions. Blood\u20082006; 107: 367\u201372.","DOI":"10.1182\/blood-2005-07-2657"},{"key":"2022061701474872500_B17","doi-asserted-by":"crossref","unstructured":"Rasmusson I, Le Blanc K, Sundberg B, Ringden O. Mesenchymal stem cells stimulate antibody secretion in human B cells. Scand J Immunol\u20082007; 65: 336\u201343.","DOI":"10.1111\/j.1365-3083.2007.01905.x"},{"key":"2022061701474872500_B18","doi-asserted-by":"crossref","unstructured":"Traggiai E, Volpi S, Schena F, et al. Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated form healthy donors and systemic lupus erythematosus patients. Stem Cells\u20082008; 26: 562\u20139.","DOI":"10.1634\/stemcells.2007-0528"},{"key":"2022061701474872500_B19","doi-asserted-by":"crossref","unstructured":"Bajenoff M, Egen JG, Koo LY, et al. Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity\u20082006; 25: 989\u20131001.","DOI":"10.1016\/j.immuni.2006.10.011"},{"key":"2022061701474872500_B20","doi-asserted-by":"crossref","unstructured":"Ame-Thomas P, Maby-El Hajjami H, Monvoisin C, et al. Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis. Blood\u20082007; 109: 693\u2013702.","DOI":"10.1182\/blood-2006-05-020800"},{"key":"2022061701474872500_B21","doi-asserted-by":"crossref","unstructured":"Lwin T, Hazlehurst LA, Li Z, et al. Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-\u03baB (RelB\/p52) in non-Hodgkin's lymphoma cells. Leukemia\u20082007; 21: 1521\u201331.","DOI":"10.1038\/sj.leu.2404723"},{"key":"2022061701474872500_B22","doi-asserted-by":"crossref","unstructured":"Zappia E, Casazza S, Pedemonte E, et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood\u20082005; 106: 1755\u201361.","DOI":"10.1182\/blood-2005-04-1496"},{"key":"2022061701474872500_B23","doi-asserted-by":"crossref","unstructured":"Ringden O, Uzunel M, Rasmusson I, et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation\u20082006; 81: 1390\u20137.","DOI":"10.1097\/01.tp.0000214462.63943.14"},{"key":"2022061701474872500_B24","doi-asserted-by":"crossref","unstructured":"Shaffer AL, Rosenwald A, Staudt LM. Lymphoid malignancies: the dark side of B-cell differentiation. Nat Rev Immunol\u20082002; 2: 920\u201332.","DOI":"10.1038\/nri953"},{"key":"2022061701474872500_B25","doi-asserted-by":"crossref","unstructured":"Canioni D, Brice P, Lepage E, et al. Bone marrow histological patterns can predict survival of patients with grade 1 or 2 follicular lymphoma: a study from the Groupe d'Etude des Lymphomes Folliculaires. Br J Haematol\u20082004; 126: 364\u201371.","DOI":"10.1111\/j.1365-2141.2004.05046.x"},{"key":"2022061701474872500_B26","doi-asserted-by":"crossref","unstructured":"Peuchmaur M, Emilie D, Crevon MC, et al. Interleukin-2 and interferon-\u03b3 production in follicular lymphomas. Am J Clin Pathol\u20081991; 95: 55\u201362.","DOI":"10.1093\/ajcp\/95.1.55"},{"key":"2022061701474872500_B27","doi-asserted-by":"crossref","unstructured":"Warzocha K, Ribeiro P, Renard N, et al. Expression of genes coding for the tumor necrosis factor and lymphotoxin ligand-receptor system in non-Hodgkin's lymphomas. Cancer Immunol Immunother\u20082000; 49: 469\u201375.","DOI":"10.1007\/s002620000127"},{"key":"2022061701474872500_B28","doi-asserted-by":"crossref","unstructured":"Widner B, Werner ER, Schennach H, Wachter H, Fuchs D. Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin Chem\u20081997; 43: 2424\u20136.","DOI":"10.1093\/clinchem\/43.12.2424"},{"key":"2022061701474872500_B29","doi-asserted-by":"crossref","unstructured":"Rohatiner AZ, Gregory WM, Peterson B, et al. Meta-analysis to evaluate the role of interferon in follicular lymphoma. J Clin Oncol\u20082005; 23: 2215\u201323.","DOI":"10.1200\/JCO.2005.06.146"},{"key":"2022061701474872500_B30","doi-asserted-by":"crossref","unstructured":"Metz R, Duhadaway JB, Kamasani U, Laury-Kleintop L, Muller AJ, Prendergast GC. Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan. Cancer Res\u20082007; 67: 7082\u20137.","DOI":"10.1158\/0008-5472.CAN-07-1872"},{"key":"2022061701474872500_B31","doi-asserted-by":"crossref","unstructured":"Terness P, Bauer TM, Rose L, et al. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med\u20082002; 196: 447\u201357.","DOI":"10.1084\/jem.20020052"},{"key":"2022061701474872500_B32","doi-asserted-by":"crossref","unstructured":"Schmitter D, Koss M, Niederer E, Stahel RA, Pichert G. T-cell derived cytokines co-stimulate proliferation of CD40-activated germinal centre as well as follicular lymphoma cells. Hematol Oncol\u20081997; 15: 197\u2013207.","DOI":"10.1002\/(SICI)1099-1069(199711)15:4<197::AID-HON614>3.0.CO;2-V"},{"key":"2022061701474872500_B33","doi-asserted-by":"crossref","unstructured":"Andersen NS, Larsen JK, Christiansen J, et al. Soluble CD40 ligand induces selective proliferation of lymphoma cells in primary mantle cell lymphoma cell cultures. Blood\u20082000; 96: 2219\u201325.","DOI":"10.1182\/blood.V96.6.2219"},{"key":"2022061701474872500_B34","doi-asserted-by":"crossref","unstructured":"Dierks C, Grbic J, Zirlik K, et al. Essential role of stromally induced hedgehog signaling in B-cell malignancies. Nat Med\u20082007; 13: 944\u201351.","DOI":"10.1038\/nm1614"},{"key":"2022061701474872500_B35","doi-asserted-by":"crossref","unstructured":"Adikari SB, Lian H, Link H, Huang YM, Xiao BG. Interferon-\u03b3-modified dendritic cells suppress B cell function and ameliorate the development of experimental autoimmune myasthenia gravis. Clin Exp Immunol\u20082004; 138: 230\u20136.","DOI":"10.1111\/j.1365-2249.2004.02585.x"},{"key":"2022061701474872500_B36","doi-asserted-by":"crossref","unstructured":"Uyttenhove C, Pilotte L, Theate I, et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med\u20082003; 9: 1269\u201374.","DOI":"10.1038\/nm934"},{"key":"2022061701474872500_B37","doi-asserted-by":"crossref","unstructured":"Muller AJ, DuHadaway JB, Donover PS, Sutanto-Ward E, Prendergast GC. Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nat Med\u20082005; 11: 312\u20139.","DOI":"10.1038\/nm1196"},{"key":"2022061701474872500_B38","doi-asserted-by":"crossref","unstructured":"Riesenberg R, Weiler C, Spring O, et al. Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma. Clin Cancer Res\u20082007; 13: 6993\u20137002.","DOI":"10.1158\/1078-0432.CCR-07-0942"},{"key":"2022061701474872500_B39","doi-asserted-by":"crossref","unstructured":"Haniffa MA, Wang XN, Holtick U, et al. Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells. J Immunol\u20082007; 179: 1595\u2013604.","DOI":"10.4049\/jimmunol.179.3.1595"},{"key":"2022061701474872500_B40","doi-asserted-by":"crossref","unstructured":"Jones S, Horwood N, Cope A, Dazzi F. The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells. J Immunol\u20082007; 179: 2824\u201331.","DOI":"10.4049\/jimmunol.179.5.2824"},{"key":"2022061701474872500_B41","doi-asserted-by":"crossref","unstructured":"Lob S, Konigsrainer A, Schafer R, Rammensee HG, Opelz G, Terness P. Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells. Blood\u20082008; 111: 2152\u20134.","DOI":"10.1182\/blood-2007-10-116111"},{"key":"2022061701474872500_B42","doi-asserted-by":"crossref","unstructured":"Scheler M, Wenzel J, Tuting T, Takikawa O, Bieber T, von Bubnoff D. Indoleamine 2,3-dioxygenase (IDO): the antagonist of type I interferon-driven skin inflammation? Am J Pathol\u20082007; 171: 1936\u201343.","DOI":"10.2353\/ajpath.2007.070281"},{"key":"2022061701474872500_B43","doi-asserted-by":"crossref","unstructured":"Dummer R, Hassel JC, Fellenberg F, et al. Adenovirus-mediated intralesional interferon-\u03b3 gene transfer induces tumor regressions in cutaneous lymphomas. Blood\u20082004; 104: 1631\u20138.","DOI":"10.1182\/blood-2004-01-0360"},{"key":"2022061701474872500_B44","doi-asserted-by":"crossref","unstructured":"Ohata J, Zvaifler NJ, Nishio M, et al. Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines. J Immunol\u20082005; 174: 864\u201370.","DOI":"10.4049\/jimmunol.174.2.864"},{"key":"2022061701474872500_B45","doi-asserted-by":"crossref","unstructured":"Djouad F, Fritz V, Apparailly F, et al. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor \u03b1 in collagen-induced arthritis. Arthritis Rheum\u20082005; 52: 1595\u2013603.","DOI":"10.1002\/art.21012"},{"key":"2022061701474872500_B46","doi-asserted-by":"crossref","unstructured":"Babcock TA, Carlin JM. Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor \u03b1 in interferon-treated epithelial cells. Cytokine\u20082000; 12: 588\u201394.","DOI":"10.1006\/cyto.1999.0661"},{"key":"2022061701474872500_B47","doi-asserted-by":"crossref","unstructured":"Byers RJ, Sakhinia E, Joseph P, et al. Clinical quantitation of immune signature in follicular lymphoma by RT-PCR based gene expression profiling. Blood\u20082008; 111: 4764\u201370.","DOI":"10.1182\/blood-2007-10-115915"},{"key":"2022061701474872500_B48","doi-asserted-by":"crossref","unstructured":"Alvaro T, Lejeune M, Salvado MT, et al. Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients. J Clin Oncol\u20082006; 24: 5350\u20137.","DOI":"10.1200\/JCO.2006.06.4766"},{"key":"2022061701474872500_B49","unstructured":"Dave SS, Wright G, Tan B, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med\u20082004; 351: 2159\u201369."},{"key":"2022061701474872500_B50","doi-asserted-by":"crossref","unstructured":"Wahlin BE, Sander B, Christensson B, Kimby E. CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma. Clin Cancer Res\u20082007; 13: 388\u201397.","DOI":"10.1158\/1078-0432.CCR-06-1734"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/7\/3228\/2623707\/3228.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/7\/3228\/2623707\/3228.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T04:52:32Z","timestamp":1655441552000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/69\/7\/3228\/553319\/Functional-Alteration-of-the-Lymphoma-Stromal-Cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,1]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2009,4,1]]},"published-print":{"date-parts":[[2009,4,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-3000","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22381529","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381526.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381526","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381538","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6499901.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381535","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381529.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6499901","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381538.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381532","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381535.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381532.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,1]]}}}